ACTO Appoints Former J&J President Lori Tierney to Board

ACTO has appointed Lori Tierney, former President of Johnson & Johnson Vision, to its Board of Directors to enhance its AI-first platform in life sciences.

ACTO Technologies, Inc. has announced the appointment of Lori Tierney to its Board of Directors, as stated in a press release. Tierney, who previously served as President of Johnson & Johnson Vision, brings over 20 years of experience in the life sciences industry.

Tierney's extensive background includes leadership roles at J&J MedTech, Mentor Aesthetics Specialty Surgery, AstraZeneca, Endo Pharmaceuticals, and Centocor. Her expertise in commercial operations and customer-centric innovation is expected to support ACTO's mission of pioneering an AI-first future in the life sciences sector.

ACTO's Intelligent Field Excellence platform aims to empower life sciences companies by providing AI-driven tools for field professionals, enhancing their engagement with healthcare providers. The platform also offers real-time insights for senior leaders to improve commercial execution.

Parth Khanna, CEO of ACTO, expressed enthusiasm about Tierney's appointment, highlighting her industry experience and vision as instrumental in advancing the company's AI initiatives.

We hope you enjoyed this article.

Consider subscribing to one of several newsletters we publish like Life AI Weekly.

Also, consider following us on social media:

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Market report

AI’s Time-to-Market Quagmire: Why Enterprises Struggle to Scale AI Innovation

ModelOp

The 2025 AI Governance Benchmark Report by ModelOp provides insights from 100 senior AI and data leaders across various industries, highlighting the challenges enterprises face in scaling AI initiatives. The report emphasizes the importance of AI governance and automation in overcoming fragmented systems and inconsistent practices, showcasing how early adoption correlates with faster deployment and stronger ROI.

Read more